90 related articles for article (PubMed ID: 7839438)
1. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy.
Granger DK; Cromwell JW; Chen SC; Goswitz JJ; Morrow DT; Beierle FA; Sehgal SN; Canafax DM; Matas AJ
Transplantation; 1995 Jan; 59(2):183-6. PubMed ID: 7839438
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin: immunosuppression, hyporesponsiveness, and side effects in a porcine renal allograft model.
Almond PS; Moss A; Nakhleh RE; Melin M; Chen S; Salazar A; Shirabe K; Matas AJ
Transplantation; 1993 Aug; 56(2):275-81. PubMed ID: 8356580
[TBL] [Abstract][Full Text] [Related]
3. Prolonged survival without posttransplant immunosuppression in a large animal model.
Granger DK; Matas AJ; Jenkins MK; Moss AA; Chen SC; Almond PS
Surgery; 1994 Aug; 116(2):236-41. PubMed ID: 8047990
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin in a porcine renal transplant model.
Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
[No Abstract] [Full Text] [Related]
5. Efficacy of rapamycin, RS-61443 and cyclophosphamide in the prolongation of survival of discordant pig to rabbit cardiac xenografts.
Yatscoff RW; Wang S; Keenan R; Chackowsky P; Lowes N; Koshal A
Can J Cardiol; 1994 Sep; 10(7):711-6. PubMed ID: 7922826
[TBL] [Abstract][Full Text] [Related]
6. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys.
Yang H; Chen G; Kanai N; Shum J; Garcia B; Huang X; Min W; Luo Y; Dutartre P; Zhong R
Transplantation; 2003 Apr; 75(8):1166-71. PubMed ID: 12717197
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of leflunomide in the canine renal transplantation model.
McChesney LP; Xiao F; Sankary HN; Foster PF; Sharma S; Haklin M; Williams JW
Transplantation; 1994 Jun; 57(12):1717-22. PubMed ID: 8016874
[TBL] [Abstract][Full Text] [Related]
8. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
Robertson A; Plenter R; Francis DM; Clunie GJ
Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
[No Abstract] [Full Text] [Related]
9. Combined rapamycin and cyclosporine immunosuppression in a porcine renal transplant model.
Granger DK; Cromwell JW; Canafax DM; Matas AJ
Transplant Proc; 1996 Apr; 28(2):984. PubMed ID: 8623488
[No Abstract] [Full Text] [Related]
10. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
11. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
12. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
[TBL] [Abstract][Full Text] [Related]
13. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
14. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
Stepkowski SM; Kahan BD
Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
[No Abstract] [Full Text] [Related]
16. Low-dose rapamycin potentiates the effects of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model.
Knight R; Ferraresso M; Serino F; Katz S; Lewis R; Kahan BD
Transplantation; 1993 Apr; 55(4):947-9. PubMed ID: 8475571
[No Abstract] [Full Text] [Related]
17. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
18. Effect of rapamycin on renal allograft survival in canine recipients treated with antilymphocyte serum, donor bone marrow, and cyclosporine.
Hartner WC; Van der Werf WJ; Lodge JP; Gilchrist B; De Fazio SR; Markees TG; Yatko C; Monaco AP; Gozzo JJ
Transplantation; 1995 Dec; 60(11):1347-50. PubMed ID: 8525533
[TBL] [Abstract][Full Text] [Related]
19. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]